T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of Continuous Intravenous Infusion of MEDI-538 in Adults With B-Cell Chronic Lymphocytic Leukemia (CLL)
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Trial of Donor Lymphocyte Infusion (DLI) and Activated DLI Following Relapse After Allogeneic Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE1
Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Lenalidomide in Chronic Lymphocytic Leukemia (CLL) Patients With Residual Disease
- Status
- COMPLETED
- Phase
- PHASE2
Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
- Status
- UNKNOWN
- Phase
- PHASE2
Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I/II Study of GX15-070MS in Untreated CLL
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT)
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Immune Responses to Influenza Vaccination With or Without Imiquimod Application in Untreated CLL Patients
- Status
- TERMINATED
- Phase
- PHASE2
In-Vivo Activated T-Cell Depletion to Prevent GVHD
- Status
- TERMINATED
- Phase
- NA
Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE1
Campath Maintenance in Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- NA
CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Investigation of the Cylex® ImmuKnow® Assay
- Status
- COMPLETED
- Phase
- N/A
Oral Valganciclovir Versus Valacyclovir
- Status
- COMPLETED
- Phase
- PHASE2
Dose Escalation Study of Gleevec and Chlorambucil in Previously Treated Chronic Lymphocytic Leukemia Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLL
- Status
- TERMINATED
- Phase
- PHASE1
Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2